The Mobility House Energizes V2G Charging System for Fremont Unified School District's Electric School Bus Fleet
Article content
FREMONT, Calif. & BELMONT, Calif. — District and school administrators hosted a ceremony on August 7th to celebrate the successful implementation of their new vehicle-to-grid (V2G) charging system at the Fremont Unified School District (FUSD) Transportation Yard. The event was co-presented by The Mobility House, and included project partners World Resources Institute, Center for Transportation and the Environment, and Polara.
Article content
'We've already seen how the electric buses can contribute to cleaner air for our community. Now, we have the opportunity to use these buses to deliver clean and reliable energy too.'
Article content
'Electric school buses, with their large batteries and predictable schedules, have tremendous potential to support the electric grid with V2G,' said Gregor Hintler, CEO North America of The Mobility House. 'We are proud to provide the technology that enables the district to drive clean and support community energy resilience.'
Article content
The commissioning represented phase one of a two-phase project which will include six bidirectional chargers, enabled for V2G participation in demand response with Pacific Gas & Electric's (PG&E) Emergency Load Reduction Program (ELRP) by The Mobility House's ChargePilot® charge management system for fleets and utility-facing market aggregation platform.
Article content
'This project is a shining example of how innovation creates a cleaner, smarter energy future,' said Mike Delaney, Vice President, Utility Partnership and Innovation, PG&E. 'We're proud to support Fremont USD and school districts across California as they convert to better, electrified student transportation.'
Article content
Here's how it works:
Article content
ChargePilot manages daily smart charging of the buses, controlled and monitored by the fleet operator in an intuitive online dashboard.
The market aggregation platform receives notifications from PG&E of an upcoming load reduction event via OpenADR, and suggests optimal charging schedules based on the event and time-of-use electricity prices.
ChargePilot adjusts charging optimization for the bus fleet to discharge power to reduce site load during the emergency event, while continuing to ensure vehicle readiness for departure on their next route.
By participating in ELRP, the fleet can greatly offset charging costs, making operations more efficient and cost-effective.
Article content
The Mobility House continuously develops its technical capabilities and programs to coordinate with utility programs for fleet vehicle-grid-integration and V2G in California and beyond, including demand response programs and dynamic rates available in other states including Massachusetts and New York.
Article content
'We've already seen how the electric buses can contribute to cleaner air for our community,' said Ernest Epley, FUSD's Director of Transportation. 'Now, we have the opportunity to use these buses to deliver clean and reliable energy too.'
Article content
The V2G infrastructure project was funded by a grant from the California Energy Commission's Clean Transportation Program.
Article content
About The Mobility House
Article content
The Mobility House is dedicated to shaping a zero-emissions future in energy and mobility. The company provides resilient charging technology that is reliable and flexible, ensuring drivers can benefit from zero emissions and zero cost charging. By integrating flexible charging with energy systems, The Mobility House helps stabilize the grid with clean energy. The company currently manages more than 2,500 EV fleet charging facilities globally, charges hundreds of thousands of electric vehicles, and manages energy storage of more than 100 MWh.
Article content
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
34 minutes ago
- Globe and Mail
What's Wrong With Vertex Pharmaceuticals Stock?
Key Points Disappointing trial results for VX-993 led to a sell-off of Vertex's stock recently. The company's financials remain strong, and sales were up 12% last quarter. Vertex has been broadening its pipeline, which can lead to much more growth in the future. 10 stocks we like better than Vertex Pharmaceuticals › Vertex Pharmaceuticals (NASDAQ: VRTX) has been a top pharma stock in recent years. It has been generating strong revenue growth while also building out its portfolio of drugs, expanding its growth opportunities in the process. This is the type of stock that you might expect to see taking off this year. But that isn't happening. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Instead, the share price of Vertex recently plunged. Excitement around the company has cooled drastically. What's wrong with Vertex Pharmaceuticals, and is it an investment worth buying on the dip, or could there be more trouble ahead for the healthcare stock? Vertex's stock tanks after underwhelming study On Aug. 4, Vertex released its latest quarterly numbers as well as results from a study for VX-993, which is a treatment for acute pain. It was the latter that had the most impact on the stock, and it wasn't good news. Vertex said that the treatment did not meet the primary endpoint in its phase 2 trial, and that it will not move on to further trials related to acute pain. The company has an approved pain medication, Journavx, which regulators approved earlier this year for moderate to severe acute pain. The non-opioid medication was a big win for the company, and investors were hoping VX-993 might be able to build on that success and potentially be a better option for patients. As is often the case with pharma stocks, bad news from a clinical trial can quickly send a stock into a tailspin. Before the recent news came out, Vertex's stock was trading at around $470. As of Tuesday, it had fallen to roughly $396. How the business looks today Despite the setback for Vertex, the business remains in solid shape. In its most recent quarter, which ended on June 30, the company's revenue rose by more than 12% year over year, to just under $3 billion. Vertex is on track to hit its guidance of around $12 billion in revenue for the full year, which would translate into an increase of 9% from the previous year. The company is a leader in cystic fibrosis drugs, and they account for nearly all of its revenue. But Vertex's business is broadening, and there is much more growth on the horizon. Journavx has only recently launched, and it brought in $12 million over the last three months. Casgevy, a gene therapy treatment for sickle cell disease and transfusion-dependent beta-thalassemia, has brought in over $30 million. Both of these products could be blockbusters, generating revenue of more than $1 billion at their respective peaks. What I like most about Vertex's business is its fantastic profit margins. Last quarter, the company's net income totaled $1 billion, which was 35% of its top line. With solid margins, the company can easily grow its profits in the long run, paving the way for a higher valuation. Vertex is a reasonably priced stock with a lot of potential upside According to analyst estimates, Vertex's stock is trading at 22 times its projected future earnings. That's modest given the average S&P 500 stock trades at a forward price-to-earnings multiple of 24. Vertex has the potential to be a tremendous growth stock to own in the long run. While the recent news around VX-993 may be disappointing, it shouldn't dissuade investors from investing in the business. Not every trial will turn out well, and not every drug will be a blockbuster. But with a growing portfolio of drugs and a highly profitable business, Vertex is one of the better healthcare stocks to buy and hold right now. Should you invest $1,000 in Vertex Pharmaceuticals right now? Before you buy stock in Vertex Pharmaceuticals, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vertex Pharmaceuticals wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,466!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,633!* Now, it's worth noting Stock Advisor's total average return is 1,077% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025
Globe and Mail
an hour ago
- Globe and Mail
Better Buy in 2025: XRP (Ripple) or Bitcoin?
Key Points Donald Trump's election win last November has been a tailwind for the cryptocurrency industry. Bitcoin remains the world's most valuable cryptocurrency, but XRP has delivered a much bigger gain since the election. One cryptocurrency has a clearer path to further upside than the other in the remainder of 2025 (and beyond). 10 stocks we like better than XRP › Donald Trump campaigned on a pro-crypto agenda in the lead-up to the U.S. presidential election last November. The total value of all coins and tokens in circulation has climbed steadily following his victory, and recently hit a new record high of $4.2 trillion. Bitcoin (CRYPTO: BTC) accounts for $2.3 trillion of that value on its own, but XRP (CRYPTO: XRP) -- while much smaller -- has delivered a much bigger gain of 500% since November. Price data by YCharts. Both cryptocurrencies have their merits, but which one might be the better buy for the remainder of this year (and beyond)? The case for XRP (Ripple) Ripple is the company behind the innovative Ripple Payments network, which uses blockchain technology to clear and settle cross-border transactions instantly. It let banks bypass intermediaries and deal with one another directly, which means transfers that used to take days can now be completed in seconds. Ripple created XRP to standardize transactions within Ripple Payments. Global banks can send XRP tokens to one another instead of sending their domestic currencies, which cuts out expensive foreign exchange fees. A transfer using XRP costs just 0.00001 tokens, which is a fraction of one U.S. cent. XRP isn't a decentralized cryptocurrency like Bitcoin, because it has to be issued by Ripple. The U.S. Securities and Exchange Commission (SEC) took issue with this arrangement, suing the company in 2020 for alleged breaches of financial securities laws. The agency argued that XRP should be treated the same as any other security which is issued by a company, like a stock or a bond. This threatened to restrict Ripple's business by placing it under a tight regulatory framework. The case was partially resolved in August 2024, when a judge ruled that XRP might only be a security in specific circumstances. But the SEC appealed the decision, which could have tied the parties up in court for several more years. However, shortly after his election win last November, Trump nominated crypto advocate Paul Atkins to run the SEC, which changed everything. The agency has since withdrawn from several of its active legal cases against crypto companies, and it dropped its appeal against Ripple on Aug. 7, which officially ended the messy five-year legal brawl. The case for Bitcoin Bitcoin is very much a speculative asset (like every other cryptocurrency). It doesn't generate any revenue or earnings, nor does it have a specific use case out in the real world, so it's only worth what the next person is willing to pay. However, a growing number of investors consider it to be a legitimate store of value, sort of like a digital version of gold, because it has several unique features. Bitcoin is completely decentralized, so it can't be controlled by any person, company, or government. It also has a capped supply of 21 million coins, which will be fully mined sometime around the year 2140. Finally, it's built on a secure and publicly verifiable blockchain, so it offers full transparency. Because of these attributes, the SEC has treated Bitcoin with far less hostility than other cryptocurrencies like XRP. In fact, the agency has approved dozens of spot Bitcoin exchange-traded funds (ETFs), which allow financial advisors and institutional investors to buy the cryptocurrency in a regulated manner. Holding an ETF is typically much safer than storing Bitcoin in a digital wallet, which can be susceptible to hacks. Analysts have wide-ranging price targets for Bitcoin. Cathie Wood from Ark Investment Management believes the cryptocurrency could hit $2.4 million by 2030, which would represent almost 2,000% upside from its current price of about $115,000. Michael Saylor from MicroStrategy, (now doing business as Strategy) on the other hand, thinks Bitcoin could completely transform the financial system by 2046, and soar 18,600% to $21 million in the process. The verdict Although XRP has a use case within Ripple Payments, banks don't have to use it to benefit from instant cross-border transactions because the network also supports fiat currencies. Therefore, the success of Ripple Payments won't necessarily translate into a higher value for XRP over the long term. In my opinion, Bitcoin has more potential for upside because of its decentralized nature. Since no person or government can manipulate or disrupt its core technology, investors' confidence in its status as a store of value should have longevity. The Bitcoin price targets presented by Cathie Wood and Michael Saylor might be a little ambitious. But if investors continue to adopt it, a more realistic target for its market capitalization might be the value of all above-ground gold reserves, which is currently $22.8 trillion. That would translate into a price-per-Bitcoin of $1,085,000, representing more than 800% upside from current levels. As a result, Bitcoin might be a better buy than XRP in the remainder of this year (and beyond). Should you invest $1,000 in XRP right now? Before you buy stock in XRP, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and XRP wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,466!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,115,633!* Now, it's worth noting Stock Advisor's total average return is 1,077% — a market-crushing outperformance compared to 185% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 18, 2025
Globe and Mail
an hour ago
- Globe and Mail
Trump to nominate top economic aide Stephen Miran to fill open spot on Federal Reserve board
U.S. President Donald Trump said Thursday he will nominate a top economic adviser to the Federal Reserve's board of governors for four months, temporarily filling a vacancy while continuing his search for a longer-term appointment. Mr. Trump said he has named Stephen Miran, the chair of the White House's Council of Economic Advisers, to fill a seat vacated by governor Adriana Kugler, a Biden appointee who is stepping down Friday. Mr. Miran, if approved by the Senate, will serve until January 31, 2026. The appointment is Mr. Trump's first opportunity to exert more control over the Fed, one of the few remaining independent federal agencies. Mr. Trump has relentlessly criticized the current chair, Jerome Powell, for keeping short-term interest rates unchanged, calling him 'a stubborn MORON' last week on social media. Mr. Miran has been a major defender of Mr. Trump's income-tax cuts and tariff hikes, arguing that the combination will generate enough economic growth to reduce budget deficits. He also has played down the risk of Mr. Trump's tariffs generating higher inflation, a major source of concern for Mr. Powell. Trump calls on Federal Reserve board to usurp Powell and take control of central bank The choice of Mr. Miran may heighten concerns about political influence over the Fed, which has traditionally been insulated from day-to-day politics. Fed independence is generally seen as key to ensuring that it can take difficult steps to combat inflation, such as raising interest rates, that politicians might be unwilling to take. Federal Reserve governors vote on all the central bank's interest-rate decisions, as well as its financial regulatory policies. Mr. Miran's nomination, if approved, would add a near-certain vote in support of lower interest rates. Ms. Kugler had echoed Mr. Powell's view that the Fed should keep rates unchanged and further evaluate the impact of tariffs on the economy before making any moves. Mr. Trump has said he will appoint a Fed chair who will cut interest rates, which he says will reduce the borrowing costs of the federal government's huge US$36-trillion debt pile. Mr. Trump also wants lower rates to boost moribund home sales, which have been held back partly by higher mortgage costs. Yet the Fed doesn't directly set longer-term interest rates for things like home and car purchases. At its most recent meeting last week Fed officials kept their key rate unchanged at 4.3 per cent, where it has stood after three rate cuts late last year. But two Fed governors – Christopher Waller and Michelle Bowman – dissented from that decision. Both were appointed by Mr. Trump in his first term. Opinion: A scary chart shows why diminished Fed independence may outlast this administration Still, even with Mr. Miran on the board, 12 Fed officials vote on interest-rate policy and many remain concerned that Mr. Trump's sweeping tariffs could push inflation higher in the coming months. Mr. Miran could be renominated to a longer term on the Fed once his initial appointment is concluded, or replaced by another nominee. Mr. Powell's term as chair ends in May 2026. Yet, Mr. Powell could remain on the board of governors until January 2028, even after he steps down as chair. That would deny, or at least delay, an opportunity for Mr. Trump to appoint an additional policymaker to the Fed's board. As a result, one option for Mr. Trump is to appoint Mr. Powell's eventual replacement as chair to replace Ms. Kugler once the remaining four months of her term are completed. Leading candidates for that position include Kevin Warsh, a former Fed governor from 2006 to 2011 and frequent critic of Mr. Powell's chairmanship, and Kevin Hassett, another top Trump economic adviser. Another option for the White House would be to select Mr. Waller, who is already on the board, to replace Mr. Powell, and who has been widely mentioned as a candidate. Marco Casiraghi, senior economist at investment bank Evercore ISI, noted that the choice of Mr. Miran could be a positive sign for Mr. Waller, because Mr. Trump did not take the opportunity to nominate someone likely to become chair once Mr. Powell steps down. After the July jobs report was released last Friday, Mr. Miran criticized the Fed chair for not cutting benchmark interest rates, saying that Mr. Trump had been proven correct on inflation during his first term and would be again. The President has pressured Mr. Powell to cut short-term interest rates under the belief that his tariffs will not fuel higher inflationary pressures. 'What we're seeing now in real time is a repetition once again of this pattern where the president will end up having been proven right,' Mr. Miran said on MSNBC. 'And the Fed will, with a lag and probably quite too late, eventually catch up to the President's view.' Last year, Mr. Miran expressed support for some unconventional economic views in commentaries on the Fed and international economics. Last November, he proposed measures that would reduce the value of the dollar in order to boost exports, reduce imports and cut the U.S. trade deficit, a top priority for Mr. Trump. He also suggested tariffs could push U.S. trading partners, such as the European Union and Japan, to accept a cheaper dollar as part of a 'Mar-a-Lago Accord,' an echo of the Plaza Accord reached in the 1980s that lowered the dollar's value. As a fellow at the conservative Manhattan Institute, Mr. Miran in March, 2024 also proposed overhauling the Fed's governance, including by making it easier for a president to fire members of its board of governors. 'The Fed's current governance has facilitated groupthink that has led to significant monetary-policy errors,' Mr. Miran wrote in a paper with Dan Katz, now a top official at the Treasury Department.
